Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2012 Sep;87(9):841-2.
doi: 10.1002/ajh.23287. Epub 2012 Jul 5.

Immune thrombocytopenia: getting back to basics

Donald M Arnold  1
Affiliations
Comment

Immune thrombocytopenia: getting back to basics

Donald M Arnold. Am J Hematol. 2012 Sep.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: D. Arnold obtained research funding for investigator-initiated studies in ITP from Amgen, GSK and Hoffman-LaRoche; and has been a member of advisory boards for Amgen and GSK.

Comment on

References

    1. Imbach P, Kuhne T, Signer E. Historical aspects and present knowledge of idiopathic thrombocytopenic purpura. Br J Hematol. 2002;119:894–900. - PubMed
    1. Sartorius JA. Steroid treatment of idiopathic thrombocytopenic purpura in children. Preliminary results of a randomized cooperative study. Am J Pediatr Hematol Oncol. 1984;6:165–169. - PubMed
    1. Imbach P, Barandun S, d’Apuzzo V, et al. High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet. 1981;1:1228–1231. - PubMed
    1. Arnold DM, Dentali F, Crowther MA, et al. Systematic review: Efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura. Ann Intern Med. 2007;146:25–33. - PubMed
    1. Cheng G, Saleh MN, Marcher C, et al. Eltrombopag for management of chronic immune thrombocytopenia (RAISE): A 6-month, randomized, phase 3 study. Lancet. 2011;377:393–402. - PubMed